These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 28152517)
1. Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro. Salpini R; Surdo M; Warner N; Cortese MF; Colledge D; Soppe S; Bellocchi MC; Armenia D; Carioti L; Continenza F; Di Carlo D; Saccomandi P; Mirabelli C; Pollicita M; Longo R; Romano S; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Iapadre N; Barlattani A; Bertoli A; Mari T; Pasquazzi C; Missale G; Sarrecchia C; Orecchini E; Michienzi A; Andreoni M; Francioso S; Angelico M; Verheyen J; Ceccherini-Silberstein F; Locarnini S; Perno CF; Svicher V Oncotarget; 2017 Feb; 8(9):15704-15715. PubMed ID: 28152517 [TBL] [Abstract][Full Text] [Related]
2. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206 [TBL] [Abstract][Full Text] [Related]
3. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro. Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417 [TBL] [Abstract][Full Text] [Related]
4. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection. Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669 [TBL] [Abstract][Full Text] [Related]
5. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development. Liang YJ; Teng W; Chen CL; Sun CP; Teng RD; Huang YH; Liang KH; Chen YW; Lin CC; Su CW; Tao MH; Wu JC Hepatology; 2021 Aug; 74(2):641-655. PubMed ID: 33675094 [TBL] [Abstract][Full Text] [Related]
6. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis. Yang Z; Zhuang L; Lu Y; Xu Q; Tang B; Chen X Oncotarget; 2016 Mar; 7(11):12525-36. PubMed ID: 26848866 [TBL] [Abstract][Full Text] [Related]
7. Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis. Li TN; Wu YJ; Tsai HW; Sun CP; Wu YH; Wu HL; Pei YN; Lu KY; Yen TT; Chang CW; Chan HL; Tao MH; Liou JY; Chang MD; Su IJ; Wang LH J Pathol; 2018 Aug; 245(4):502-513. PubMed ID: 29862509 [TBL] [Abstract][Full Text] [Related]
8. Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels Salpini R; Battisti A; Piermatteo L; Carioti L; Anastasiou OE; Gill US; Di Carlo D; Colagrossi L; Duca L; Bertoli A; La Rosa KY; Fabeni L; Iuvara A; Malagnino V; Cerva C; Lichtner M; Mastroianni CM; De Sanctis GM; Paoloni M; Marignani M; Pasquazzi C; Iapadre N; Parruti G; Vecchiet J; Sarmati L; Andreoni M; Angelico M; Grelli S; T Kennedy P; Verheyen J; Aquaro S; Silberstein FC; Perno CF; Svicher V Emerg Microbes Infect; 2020 Dec; 9(1):928-939. PubMed ID: 32312174 [TBL] [Abstract][Full Text] [Related]
9. Different pre-S deletion patterns and their association with hepatitis B virus genotypes. Chen BF World J Gastroenterol; 2016 Sep; 22(35):8041-9. PubMed ID: 27672298 [TBL] [Abstract][Full Text] [Related]
10. Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma. Kao JH; Liu CJ; Jow GM; Chen PJ; Chen DS; Chen BF Liver Int; 2012 Oct; 32(9):1373-81. PubMed ID: 22676233 [TBL] [Abstract][Full Text] [Related]
11. The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing. Wang Y; Xiao X; Chen S; Huang C; Zhou J; Dai E; Li Y; Liu L; Huang X; Gao Z; Wu C; Fang M; Gao C Front Immunol; 2021; 12():775461. PubMed ID: 34899733 [TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant. Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165 [TBL] [Abstract][Full Text] [Related]
13. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH Gastroenterology; 2012 May; 142(5):1140-1149.e3; quiz e13-4. PubMed ID: 22333950 [TBL] [Abstract][Full Text] [Related]
14. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma. Lee D; Lyu H; Chung YH; Kim JA; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ; Ryu SH World J Gastroenterol; 2016 Jun; 22(23):5393-9. PubMed ID: 27340355 [TBL] [Abstract][Full Text] [Related]
15. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk. Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778 [TBL] [Abstract][Full Text] [Related]
16. Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma. Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Tuvin D; Hiotis SP J Med Virol; 2016 Feb; 88(2):244-51. PubMed ID: 26174662 [TBL] [Abstract][Full Text] [Related]
17. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma. Park YM; Jang JW; Yoo SH; Kim SH; Oh IM; Park SJ; Jang YS; Lee SJ J Viral Hepat; 2014 Mar; 21(3):171-7. PubMed ID: 24344773 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma and hepatitis B surface protein. Li YW; Yang FC; Lu HQ; Zhang JS World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602 [TBL] [Abstract][Full Text] [Related]
19. Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection. Mirabelli C; Surdo M; Van Hemert F; Lian Z; Salpini R; Cento V; Cortese MF; Aragri M; Pollicita M; Alteri C; Bertoli A; Berkhout B; Micheli V; Gubertini G; Santoro MM; Romano S; Visca M; Bernassola M; Longo R; De Sanctis GM; Trimoulet P; Fleury H; Marino N; Mazzotta F; Cappiello G; Spanò A; Sarrecchia C; Zhang JM; Andreoni M; Angelico M; Verheyen J; Perno CF; Svicher V J Infect; 2015 Mar; 70(3):288-98. PubMed ID: 25452041 [TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells. Song J; Zhang X; Ge Q; Yuan C; Chu L; Liang HF; Liao Z; Liu Q; Zhang Z; Zhang B J Cell Biochem; 2018 Nov; 119(10):8419-8431. PubMed ID: 29904948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]